|
n
|
27
|
28
|
–
|
|
Age
|
39.2 ± 8.8
|
47.6 ± 10.9
|
0.002
|
|
Sex (female)
|
25 (92.6%)
|
24 (85.7%)
|
0.669
|
|
Duration of migraine (years)
|
22.6 ± 9.7
|
30.8 ± 12.1
|
0.013
|
|
Duration of chronic migraine (years)
|
–
|
12.2 ± 10.8
|
–
|
|
Duration of medication overuse (years)
|
–
|
8.6 ± 6.4
|
–
|
|
Migraine days per month
|
6.9 ± 2.4
|
23.6 ± 5.3
|
0.001
|
|
Headache days per month
|
7.2 ± 2.4
|
26.2 ± 5.2
|
0.001
|
|
Days of acute drug intake per month
|
6.7 ± 2.2
|
23.2 ± 5.6
|
0.001
|
|
Doses of acute drugs per month
|
7.2 ± 2.7
|
51.5 ± 60.5
|
0.001
|
|
Migraine with aura
|
5 (18.5%)
|
7 (25.0%)
|
0.746
|
|
Preventive therapy at baseline
|
10 (37.0%)
|
10 (35.7%)
|
1.000
|
|
Previous detoxification
|
–
|
32.1%
|
–
|
|
Acute treatment
|
|
NSAID
|
13 (48.1%)
|
14 (50.0%)
|
0.845
|
|
Triptan
|
8 (29.6%)
|
7 (25.0%)
|
|
Combination
|
4 (14.8%)
|
6 (21.4%)
|
|
Politherapy
|
2 (7.4%)
|
1 (3.6%)
|
